Holy Young BioMedical Co., Ltd.
Update：2026/08/06
Industries
Main Industry
Health Care
Main Product/Service
Operating global medical distribution channels, including product agency and distribution services for its parent company, Holy Stone Healthcare; introducing and representing A New Generation Test Tool for Detecting Latent Tuberculosis Infection (QFT-Plus); and World Patent-Protected Hyaluronic Acid Injection for Tendon and Ligament Injuries (SportVis™).
Founded Year
2023
Unified Business No.
93497259
Status
Active
Total Paid-in
Capital
110,820,680 (NT$)
Location of Company
Taiwan
, Taipei City
Information such as company name, company status, responsible person, year of establishment, paid-in capital, and registered address is sourced from the Commercial and Industrial Registration Office of the Ministry of Economic Affairs; listing status includes emerging stock, M&A, and IPO; overseas development is provided by the startup itself.
Notice: This data is compiled from public sources for reference only. We have no direct affiliation with the company and are not their contact person.
Exclusive content for members
Members-only content. Please log in to access.
About the Company
Holy Young BioMedical was spun off from Holy Stone Healthcare in 2024. It manages distribution operations in Taiwan and oversees MDT International’s branded medical device business in Europe. The company leverages global distribution networks to expand new indications, products, and markets, focusing on innovative medical technologies and global healthcare delivery.
